Cleary Gottlieb represented the underwriters, led by Barclays Capital, Citigroup Global Markets, Goldman Sachs and Morgan Stanley, in an SEC-registered offering by Teva Pharmaceutical Industries Limited and its affiliates of $5,000,000,000 aggregate principal amount of guaranteed senior notes. The notes were issued in six series by three of Teva’s finance subsidiaries, organized under the laws of Curacao and Delaware, and are fully guaranteed by Teva. The transaction priced on November 7 and closed on November 10.
Teva, which is incorporated and headquartered in Israel, is the world’s leading generic drug company, measured by prescriptions filled, as well as the leading generic drug company in the United States, measured on the same basis. In addition, Teva has a significant branded pharmaceuticals portfolio, including treatments for multiple sclerosis and Parkinson’s disease as well as respiratory products and women’s health products.
